MGO One Seven’s Agios Pharmaceuticals AGIO Stock Holding History

MGO One Seven’s Portfolio AGIO Stock Details AGIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-59	Closed	-$2K	–	446
2018 Q4	$2K	Buy	+59	New	+$3.64K	﹤0.01%	1537
2018 Q1	$8K	Hold	93	–	–	﹤0.01%	1150
2017 Q4	$5K	Buy	+93	New	+$5.85K	﹤0.01%	1286

Other funds holding AGIO

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

WIM

Woodford Investment Management London, United Kingdom $310M AUM 17.41% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

MGO One Seven's AGIO Position: Q1 2019 in Review

MGO One Seven sold out of Agios Pharmaceuticals (AGIO) in Q1 2019, closing a stake of 59 shares — an estimated $2K sold.

MGO One Seven first reported a position in AGIO in Q4 2017 and held it in 3 quarters. The position peaked at $8K in Q1 2018. 201 funds tracked by Wall St. Rank hold AGIO as of Q1 2019.

MGO One Seven reported no remaining Agios Pharmaceuticals position as of Q1 2019 after selling out during the quarter.
MGO One Seven sold 59 Agios Pharmaceuticals shares in Q1 2019, an estimated $2K.
MGO One Seven first reported a position in Agios Pharmaceuticals in Q4 2017 and held it in 3 quarters.
MGO One Seven's Agios Pharmaceuticals position peaked at $8K in Q1 2018.
201 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q1 2019.

Based on MGO One Seven's 13F filing for Q1 2019, filed 9 Apr 2019.